Subgroup analysis based on sex, age, race, different lymph node metastasis status, and tumor stage showed that the expression level of SLC2A5 in LUAD patients increased relative to normal samples (Figures 2(b)–2(f)). The gene discussed is SLC2A5; the disease is neoplasm.